Cite

HARVARD Citation

    Hsu, C. et al. (2016). Improved antithrombotic activity and diminished bleeding side effect of a PEGylated αIIbβ3 antagonist, disintegrin. Thrombosis research. pp. 3-10. [Online]. 
  
Back to record